 |
|
UCLA stem cells scientists make electrically active motor neurons from iPS cells
February 25, 2009Discovery demonstrates the feasibility of using iPS-derived motor neurons to model and treat diseases
Stem cells scientists at UCLA showed for the first time that human induced pluripotent stem (iPS) cells can be differentiated into electrically active motor neurons, a discovery that may aid in studying and treating neurological disorders.
Additionally, the motor neurons derived from the iPS cells appeared to be similar in function and efficiency to those derived from human embryonic stem cells, although further testing needs to be done to confirm that. If the similarities are confirmed, the discovery may open the door for new treatments for neurological disorders using patient-specific cells.
The study appears today in the early online edition of the journal Stem Cells. It can be accessed here: http://www.stemcells.com/view/0/index.html.
"It is clear from the literature that you can make at least immature versions of many different kinds of cells from human iPS cells," said William Lowry, a Broad Stem Cell Research Center scientist, an assistant professor of molecular, cell and developmental biology and senior author of the study. "But there is not a lot of data published describing the generation of fully functional cells from human iPS cells."
Lowry and his team used skin fibroblasts and reprogrammed them back into an embryonic state, with the ability to differentiate into any cell type in the human body. They then took those cells and differentiated them into motor neurons.
Neurons are the responsive cells in the nervous system that process and transmit information by electrochemical signaling. Motor neurons receive signals from the brain and spinal cord and regulate muscle contraction.
The study demonstrates the feasibility of using iPS-derived motor neurons and their progenitors to replace damaged or dead motor neurons in patients with certain disorders. It also opens the possibility of studying motor neuron-related diseases in the laboratory to uncover their causes. Motor neurons are lost in many conditions, including spinal cord injury, Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy.
"A primary objective of human embryonic stem cell and human iPS cell technology is to be able to generate relevant cell types to enable the repair of tissue damage and in vitro modeling of human disease processes," the study states. "Here, we demonstrate the successful generation of electrically active motor neurons from multiple human iPS cell lines and provide evidence that these neurons are molecularly and physiologically indistinguishable from motor neurons derived from human embryonic stem cells."
Much may be learned from studying the iPS-derived motor neurons and comparing them to motor neurons derived from patients with neurological disorders to see how they differ. The next step for Lowry and his team is to combine the motor neurons with muscle cells to see if they can stimulate a response. If they do, researchers should be able to see the muscle cells contract.
University of California - Los Angeles
The study appears today in the early online edition of the journal Stem Cells. It can be accessed here: http://www.stemcells.com/view/0/index.html.
"It is clear from the literature that you can make at least immature versions of many different kinds of cells from human iPS cells," said William Lowry, a Broad Stem Cell Research Center scientist, an assistant professor of molecular, cell and developmental biology and senior author of the study. "But there is not a lot of data published describing the generation of fully functional cells from human iPS cells."
Lowry and his team used skin fibroblasts and reprogrammed them back into an embryonic state, with the ability to differentiate into any cell type in the human body. They then took those cells and differentiated them into motor neurons.
Neurons are the responsive cells in the nervous system that process and transmit information by electrochemical signaling. Motor neurons receive signals from the brain and spinal cord and regulate muscle contraction.
The study demonstrates the feasibility of using iPS-derived motor neurons and their progenitors to replace damaged or dead motor neurons in patients with certain disorders. It also opens the possibility of studying motor neuron-related diseases in the laboratory to uncover their causes. Motor neurons are lost in many conditions, including spinal cord injury, Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy.
"A primary objective of human embryonic stem cell and human iPS cell technology is to be able to generate relevant cell types to enable the repair of tissue damage and in vitro modeling of human disease processes," the study states. "Here, we demonstrate the successful generation of electrically active motor neurons from multiple human iPS cell lines and provide evidence that these neurons are molecularly and physiologically indistinguishable from motor neurons derived from human embryonic stem cells."
Much may be learned from studying the iPS-derived motor neurons and comparing them to motor neurons derived from patients with neurological disorders to see how they differ. The next step for Lowry and his team is to combine the motor neurons with muscle cells to see if they can stimulate a response. If they do, researchers should be able to see the muscle cells contract.
University of California - Los Angeles
Motor Neurons Current Events and Motor Neurons News RSSResearchers identify drug candidate for treating spinal muscular atrophy
A chemical cousin of the common antibiotic tetracycline might be useful in treating spinal muscular atrophy (SMA), a currently incurable disease that is the leading genetic cause of death in infants.
Compound shows potential for slowing progression of ALS
A chemical cousin of a drug currently used to treat sepsis dramatically slows the progression of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, in mice.
Scientists demonstrate link between genetic defect and brain changes in schizophrenia
Researchers at the University of North Carolina at Chapel Hill School of Medicine have found that the 22q11 gene deletion - a mutation that confers the highest known genetic risk for schizophrenia - is associated with changes in the development of the brain that ultimately affect how its circuit elements are assembled.
Scientists encouraged by new mouse model's similarities to human ALS
A new mouse model of amyotrophic lateral sclerosis (ALS) closely resembles humans with the paralyzing disorder, researchers at Washington University School of Medicine in St. Louis report.
Amyotrophic lateral sclerosis may involve a form of sudden, rapid aging of the immune system
Premature aging of the immune system appears to play a role in the development of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to research scientists from the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center, the Weizmann Institute of Science in Israel, and Sheba Medical Center in Israel.
Avian influenza strain primes brain for Parkinson's disease
At least one strain of the H5N1 avian influenza virus leaves survivors at significantly increased risk for Parkinson's disease and possibly other neurological problems later in life.
UMMS researchers isolate first 'neuroprotective' gene in patients with amyotrophic lateral sclerosis
A genetic variant that substantially improves survival of individuals with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
The secret to chimp strength
February's brutal chimpanzee attack, during which a pet chimp inflicted devastating injuries on a Connecticut woman, was a stark reminder that chimps are much stronger than humans-as much as four-times stronger, some researchers believe.
Researchers identify ALS gene mutation
Research that has discovered a new gene whose mutations cause 5 percent of inherited cases of ALS (amyotrophic lateral sclerosis) is part of a national study led by the Northwestern University Feinberg School of Medicine.
RSRT Advisor Makes Significant Discovery with Potential for Novel Therapeutic Approaches
A paper published online today in Nature Neuroscience reveals the presence of methyl CpG binding protein 2 (MeCP2) in glia. MeCP2 is a protein associated with a variety of neurological disorders, including Rett Syndrome, the most physically disabling of the autism spectrum disorders.
More Motor Neurons Current Events and Motor Neurons News Articles
 |
Waging a War against Motor Neuron Disease: On the Frontier of Translational Research for Lou Gehrig's Disease by Page Jones (Author) Despite the great strides that have been made in research for Lou Gehrig?s Disease in the twentieth century, effective treatments are sorely lacking. This is a devastating neurodegenerative disorder that progresses rapidly to paralysis and death. What will we do to address treatment options? Waging a War against Motor Neuron Disease describes the development of a cell model and biochemical assays that may lead to the discovery of mechanisms of ALS. This original work provides groundbreaking evidence that proteomics analysis in spinal cord extracts of ALS mice may yield new protein targets and suggests that therapeutic approaches can be derived from developments in the laboratory. This book describes translational research that is leading to promising... |
 |
Motor Neuron Diorama DG167 by Anatomical Chart Company More than 2500 times magnified motor nerve cell shows the cytological ultra-structure, organelles and inclusions within the cell body. A section of the axon lifts off. Key card identifies 54 structures. Size: 17" x 8" x 11". Ideal for classroom use. |
 |
Motor Neuron Diorama by Anatomical Chart Company A more than 2,500-times magnified motor-nerve cell is shown in its functional setting. The 3-dimensional neuron shows the cytological ultra-structure, organelles, and inclusions within the cell body. A section of the axon lifts off to expose the myelin sheath and neurolemma, and Schwann cell. Key identifying 54 features included. Size: 17" x 8" x 11". Denoyer-Geppert Co. |
 |
Motor Speech Disorders by Frederic L. Darley (Author), Arnold Elvin Aronson (Author), Joe Robert Brown (Author) |
 |
Motor Neuron Diorama by LWW A more than 2,500-times magnified motor-nerve cell is shown in its functional setting. The 3-dimensional neuron shows the cytological ultra-structure, organelles, and inclusions within the cell body. A section of the axon lifts off to expose the myelin sheath and neurolemma, and Schwann cell. Key identifying 54 features included. Size: 17" x 8" x 11". Denoyer-Geppert Co. |
 |
Motor Neuron Disorders and Related Diseases: Handbook of Clinical Neurology (Series Editors: Aminoff, Boller and Swaab) by Andrew Eisen (Editor), Pamela J. Shaw MD (Editor) This volume in the Handbook of Clinical Neurology (Series Editors: Michael J. Aminoff, Department of Neurology, University of California, San Francisco, USA; François Boller, Bethesda, USA; Dick F. Swaab, Netherlands Institute for Neuroscience, Amsterdam, the Netherlands) on motor neuron disorders and related diseases deals with the remarkable advances that have occured in recent years in the understanding of these disorders and their underlying molecular pathogenesis. An account is also provided of the general clinical features and mangement of these devasting disorders, which will be invaluable to all those who care for patients affected by them. |
 |
Motor Neuron Disease by Kunel (Author), Rutherford (Author), John L.R. Forsythe (Author), Ralph W. Kuncl MD PhD (Editor) Motor Neuron Disease is a state of the art monograph designed for the clinician who wants to stay on the cutting edge of the scientific understanding of motor neuron disease. The three most common motor neuron diseases are covered, namely sporadic amyotrophic lateral sclerosis, familial amyotrophic lateral sclerosis and childhood spinal muscular atrophy. Succinct, well referenced and supported by appropriate illustrations the scope of the book includes current accepted diagnostic criteria for ALS, including practical case histories to aid differential diagnosis. The most common theories of pathogenesis are examined, and the most up to date review of the genetic implications for familial ALS included. A chapter on treatment includes coverage of the latest anti-excitotoxic drugs, in... |
 |
Motor Neuron Disease (The Facts) by Kevin Talbot (Author), Rachael Marsden (Author) Motor neuron disease (MND) is a common but devastating disability that has a profound impact on people's lives. This book provides an easily-accessible guide to the disease for patients with motor neuron disease and their carers. The authors have organised it around a series of the commonest questions asked in their clinic, emphasising the variation in the course of MND and the individual nature of the patient journey through the disease. After an initial description of the symptoms for MND and how neurologists make the diagnosis the authors describe what is known about the causes and how scientists are trying to understand the disease. The book also looks at how a team of specialists can provide support and symptom control for the patient. |
 |
Motor Neurobiology of the Spinal Cord (Methods and New Frontiers in Neuroscience) by Timothy C. Cope (Editor) Traumatic injuries of the spinal cord continue to be the most common cause of permanent paralysis in young adults in the United States. New information has emerged on the response of spinal neurons to injury of either the spinal cord or peripheral nerves demonstrating that dendrites of injured motoneurons take on characteristics of axons. These and other new developments have helped to promote an exciting new era in the study of spinal cord neurobiology.Motor Neurobiology of the Spinal Cord provides a description of the recent conceptual and technical advances in the field. It provides a description of the new experimental tools available for investigating the neuronal properties that allow populations of spinal cord neurons to control muscles responsible for limb movements and posture.... |
 |
Motor Neuron Disorders (Blue Books of Practical Neurology) by Pamela J., M.d. Shaw (Editor), Michael J. Strong (Editor) Leading international and authoritative experts presents state-of-the-art knowledge and key principles in the clinical diagnosis, pathology, and investigation of motor neuron disorders. |
| © 2009 BrightSurf.com |